Laboratory Corporation of America Holdings at Credit Suisse Healthcare Conference (Virtual) Transcript
All right. Thank you, A.J. Good afternoon, everybody. It's really a pleasure to be here with you today. It's pretty remarkable. I recently marked my 2-year anniversary as CEO of LabCorp. And in just a month or 2, we will be approaching 2 years since the start of the COVID-19 pandemic. We started to hear about it and react to it in January of 2020, where we had significant issues in Asia, and we began to realize that the rest of the world was going to face similar issues.
Needless to say, no one could have imagined how much the world would change over those 2 years. What I can tell you is Labcorp continues to fight against the pandemic in every way possible by our Diagnostic capabilities, together with our Drug Development capabilities. We've done over 60 million COVID tests to date, and we continue to innovate. So we recently announced that we now have an at-home collection kit for both flu and COVID that can be used for people, children ages 2 and older. And once again, no upfront out-of-pocket costs
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |